Company / R&D per Share
Design Therapeutics, Inc. R&D per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.78
FY2025
5-year range
$0.38 / $1.01
FY2021-FY2025
Trend
-22.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $0.38 to $0.78 over the past 4 years.
Based on SEC 10-K filings.
0.78 in FY2025.
Improved from $0.38 to $0.78 over the past 4 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, r&d per share decreased 22.7% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -6.59 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.78 | -22.7% |
| FY2024 | $1.01 | +166.1% |
| FY2021 | $0.38 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026